Low-intensity Oral Anticoagulation Versus High-intensity Oral Anticoagulation in Patients with Mechanical Bileaflet Prosthetic Heart Valves |
Jeong, Seong-Cheol
(Department of Thoracic and Cardiovascular Surgery, National Medical Center)
Kim, Mi-Jung (Department of Thoracic and Cardiovascular Surgery, National Medical Center) Song, Chang-Min (Department of Thoracic and Cardiovascular Surgery, National Medical Center) Kim, Woo-Shik (Department of Thoracic and Cardiovascular Surgery, National Medical Center) Shin, Yong-Chul (Department of Thoracic and Cardiovascular Surgery, National Medical Center) Kim, Byung-Yul (Department of Thoracic and Cardiovascular Surgery, National Medical Center) |
1 | ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148. DOI ScienceOn |
2 | Butchart EG, Lewis PA, Bethel JA, et al. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors: recommendations for the Medtronic Hall valve. Circulation 1991;84:III61-9. |
3 | Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993;2:291-301. PUBMED |
4 | Dang MT, Hambleton J, Kayser SR. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother 2005;39:1008-12. DOI ScienceOn |
5 | Yuan HY, Chen JJ, Lee MT, et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 2005;14:1745-51. DOI ScienceOn |
6 | Takahashi H, Wilkinson GR, Nutescu EA, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African- Americans. Pharmacogenet Genomics 2006;16:101-10. DOI PUBMED ScienceOn |
7 | Stein PD, Alpert JS, Bussey HI, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220S-7S. DOI ScienceOn |
8 | Susana SM, Carlos GF, Juan F, et al. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prostehtic heart valves. J Thorac Cardiovasc Surg 1997;113:910-6. DOI ScienceOn |
9 | Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-12. DOI PUBMED ScienceOn |
10 | Butchart EG, Lewis PA, Grunkemeier GL, et al. Low risk of thrombosis and serious embolic events despite low- intensity anticoagulation: experience with 1,004 Medtronic Hall valves. Circulation 1988;78:I66-77. |
11 | Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329: 524-9. DOI ScienceOn |
12 | Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7. DOI ScienceOn |
13 | Saour JN, Sieck JO, Mamo LA, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-32. DOI PUBMED ScienceOn |
14 | Vogt S, Hoffmann A, Roth J, et al. Heart valve replacement with the Bjork-Shiley and St Jude Medical prostheses: a randomized comparison in 178 patients. Eur Heart J 1990;11:583-91. DOI PUBMED |
15 | Cho HJ, Sohn KH, Park HM, et al. Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Pharmacogenomics 2007;8:329-37. DOI ScienceOn |
16 | Dale J, Myhre E, Storstein O, et al. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves. Am Heart J 1977;94:101-11. DOI PUBMED ScienceOn |
17 | You JH, Chan FW, Wong RS, et al. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol 2005;59:582-7. DOI ScienceOn |
18 | Horstkotte D, Schulte HD, Bircks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-45. PUBMED |
19 | Jegaden O, Eker A, Delahaye F, et al. Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve. Ann Thorac Surg 1994;58: 1721-8. DOI PUBMED ScienceOn |
20 | Altman R, Boullon F, Rouvier J, et al. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg 1976;72:127-9. PUBMED |